Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-10-9
pubmed:abstractText
Rats with congestive heart failure (CHF) develop ventricular inotropic responsiveness to serotonin (5-HT), mediated through 5-HT(2A) and 5-HT(4) receptors. Human ventricle is similarly responsive to 5-HT through 5-HT(4) receptors. We studied isolated ventricular cardiomyocytes to clarify the effects of 5-HT on intracellular Ca(2+) handling. Left-ventricular cardiomyocytes were isolated from male Wistar rats 6 wk after induction of postinfarction CHF. Contractile function and Ca(2+) transients were measured in field-stimulated cardiomyocytes, and L-type Ca(2+) current (I(Ca,L)) and sarcoplasmic reticulum (SR) Ca(2+) content were measured in voltage-clamped cells. Protein phosphorylation was measured by Western blotting or phosphoprotein gel staining. 5-HT(4)- and 5-HT(2A)-receptor stimulation induced a positive inotropic response of 33 and 18% (both P < 0.05) and also increased the Ca(2+) transient (44 and 6%, respectively; both P < 0.05). I(Ca,L) and SR Ca(2+) content increased only after 5-HT(4)-receptor stimulation (57 and 65%; both P < 0.05). Phospholamban serine(16) (PLB-Ser(16)) and troponin I phosphorylation increased by 26 and 13% after 5-HT(4)-receptor stimulation (P < 0.05). 5-HT(2A)-receptor stimulation increased the action potential duration and did not significantly change the phosphorylation of PLB-Ser(16) or troponin I, but it increased myosin light chain 2 (MLC2) phosphorylation. In conclusion, the positive inotropic response to 5-HT(4) stimulation results from increased I(Ca,L) and increased phosphorylation of PLB-Ser(16), which increases the SR Ca(2+) content. 5-HT(4) stimulation is thus, like beta-adrenoceptor stimulation, possibly energetically unfavorable in CHF. 5-HT(2A)-receptor stimulation, previously studied in acute CHF, induces a positive inotropic response also in chronic CHF, probably mediated by MLC2 phosphorylation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channels, L-Type, http://linkedlifedata.com/resource/pubmed/chemical/Calcium-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Cardiac Myosins, http://linkedlifedata.com/resource/pubmed/chemical/Cardiotonic Agents, http://linkedlifedata.com/resource/pubmed/chemical/GR 113808, http://linkedlifedata.com/resource/pubmed/chemical/Indoles, http://linkedlifedata.com/resource/pubmed/chemical/Isoproterenol, http://linkedlifedata.com/resource/pubmed/chemical/Ketanserin, http://linkedlifedata.com/resource/pubmed/chemical/Myosin Light Chains, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Serotonin, 5-HT2A, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Serotonin, 5-HT4, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin 5-HT2 Receptor Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin 5-HT4 Receptor Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/Troponin I, http://linkedlifedata.com/resource/pubmed/chemical/myosin light chain 2, http://linkedlifedata.com/resource/pubmed/chemical/phospholamban
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0363-6135
pubmed:author
pubmed:issnType
Print
pubmed:volume
293
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
H2367-76
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:17660386-Action Potentials, pubmed-meshheading:17660386-Adrenergic beta-Agonists, pubmed-meshheading:17660386-Animals, pubmed-meshheading:17660386-Calcium Channels, L-Type, pubmed-meshheading:17660386-Calcium Signaling, pubmed-meshheading:17660386-Calcium-Binding Proteins, pubmed-meshheading:17660386-Cardiac Myosins, pubmed-meshheading:17660386-Cardiotonic Agents, pubmed-meshheading:17660386-Coronary Vessels, pubmed-meshheading:17660386-Disease Models, Animal, pubmed-meshheading:17660386-Heart Failure, pubmed-meshheading:17660386-Indoles, pubmed-meshheading:17660386-Isoproterenol, pubmed-meshheading:17660386-Ketanserin, pubmed-meshheading:17660386-Ligation, pubmed-meshheading:17660386-Male, pubmed-meshheading:17660386-Myocardial Contraction, pubmed-meshheading:17660386-Myocardial Infarction, pubmed-meshheading:17660386-Myocytes, Cardiac, pubmed-meshheading:17660386-Myosin Light Chains, pubmed-meshheading:17660386-Phosphorylation, pubmed-meshheading:17660386-Rats, pubmed-meshheading:17660386-Rats, Wistar, pubmed-meshheading:17660386-Receptor, Serotonin, 5-HT2A, pubmed-meshheading:17660386-Receptors, Serotonin, 5-HT4, pubmed-meshheading:17660386-Sarcoplasmic Reticulum, pubmed-meshheading:17660386-Serotonin, pubmed-meshheading:17660386-Serotonin 5-HT2 Receptor Antagonists, pubmed-meshheading:17660386-Serotonin 5-HT4 Receptor Antagonists, pubmed-meshheading:17660386-Serotonin Antagonists, pubmed-meshheading:17660386-Sulfonamides, pubmed-meshheading:17660386-Time Factors, pubmed-meshheading:17660386-Troponin I, pubmed-meshheading:17660386-Ventricular Function
pubmed:year
2007
pubmed:articleTitle
Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes.
pubmed:affiliation
Institute for Experimental Medical Research, Ullevaal Univ. Hospital, Kirkeveien 166, 0407 Oslo, Norway. j.a.birkeland@medisin.uio.no
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't